calcineurin. NFAT is a substrate of calcineurin and directly dephosphorylated at multiple sites (11) . Recent genetic studies have suggested the different importance of two major isoforms of calcineurin in T cell development and function, due to their different expression levels in T cells (12, 13) . The phenotypic analyses of calcineurin Aβ-deficient mice demonstrated a defective immune response that was similar to CsA treatment, while only modest immunologic phenotype was observed in calcineurin Aα-deficient mice.
While targeted disruption of the gene of single calcineurin isoform greatly improved our knowledge concerning calcineurin participation in immunosuppression, the indirect mode of action of CsA via a presenter protein renders the drug effect less clear in vivo. For instance, both calcineurin Aα -/-and calcineurin Aβ -/-T cells remained sensitive to CsA inhibition (12, 13 ).
Fortunately, chemical genetics studies would provide an alternative approach to answer these questions (14) . Small molecule compounds with inhibitory potency and specificity towards Cyp18 and calcineurin different from that of CsA could help us to distinguish between the Cyp18 and calcineurin inhibition involved in cellular effects of CsA. As a first step, the design of CsA derivatives that could inhibit calcineurin in a Cyp18 independent manner, and thus renders calcineurin inhibition independent of the intrinsic cyclophilins of the targeted cells, would seem to be ideal to dissect the numerous biological effects of CsA.
Here we describe CsA derivatives, in which a single hydrogen atom of sarcosine at position 3 (Sar 3 ) has been replaced by either alkyl or alkylthio groups (15) , bypassing the requirement for Cyp18 binding in calcineurin inhibition. Sar 3 had been chosen for modification due to its importance in the control of the CsA conformation (16 
Enzyme activity assays

RII phosphopeptide based calcineurin activity assay
The biotinylated and nonbiotinylated 19-residue peptides of a partial sequence of the RII subunit of the bovine PKA were phosphorylated at residue 15 as previously described (24) . For all calcineurin activity assays, the [ 33 P] labeled RII phosphopeptide was used.
Calcineurin activity was measured using a scintillation proximity assay (24) . In brief, preincubation of calmodulin (50 nM), calcineurin (1.32 nM), and inhibitor at the required concentrations in phosphatase assay buffer (40 mM Tris/HCl, pH 7.5; 100 mM NaCl, 6 mM MgCl 2 , 0.5 mM DTT, 1 mM CaCl 2 , 0.1 mg/ml BSA) was carried out at 22°C for 30 min in a 96-well microtiter plate (Costar, Bodenheim, Germany). 10 pmol biotinylated [ 33 
P] RII
phosphopeptide was added to each well in a total assay volume of 100 µl. After dephosphorylation of RII phosphopeptide by calcineurin at 30°C for 20 min, 90 µl of the reaction mixture were transferred to a scintillation well coated with streptavidin (Perkin Elmer, Germany).
Biotinylated RII phosphopeptide was allowed to bind to streptavidin for 20 min at 22°C. with a calcineurin concentration of 0.66 nM.
pNPP based calcineurin activity assay
Phosphatase activity was measured at room temperature using p-nitrophenyl phosphate (pNPP) as substrate in phosphatase assay buffer (see above). After preincubation of calcineurin and calmodulin with the inhibitor in phosphatase assay buffer at room temperature for 20 min, the reaction was initiated by the addition of pNPP to a final concentration of 10 mM. The release of p-nitrophenol was continuously measured using a Dynatec MR7000 microtiterplate reader at 410 nm for 45 min. 
Inhibition of other protein Ser/Thr phosphatases
Peptidyl-prolyl cis/trans-isomerase assay
PPIase activity was determined with oligopeptide substrates using protease-coupled assays as described elsewhere (27) . Typically, experiments were performed with the PPIase concentrations in the low nM range and CsA or CsA derivatives within the assay. The effect of the inhibitors on the PPIase activity was calculated from the remaining activity after preincubation of the enzyme and the inhibitor at 22°C for 20 min.
Reversibility of calcineurin inhibition
The For experiments with additional cytokines, sorted T cells were used and IL-2 (10 IU/ml), IL-7 (10 ng/ml), and IL-15 (10 ng/ml) were added just before stimulation.
Intracellular cytokine production
PBMCs (2x10 Sorted T cells were used in experiments with exogenous cytokines, and IL-2 (10 IU/ml), IL-7 (10 ng/ml), and IL-15 (10 ng/ml) were added just before stimulation.
Luciferase reporter gene assays
Sorted T cells transfected with the NFAT-reporter plasmid (Stratagene, Netherlands) by electroporation (Amaxa, Cologne, Germany), were cultured in RPMI 1640 with 10% FCS and 2 mM L-glutamine for 16 h at 37°C in 5% CO 2 . The cells were preincubated with inhibitors for 30 min and then stimulated with 10 ng/ml PMA and 1 µg/ml ionomycin for 5 h. After cell lysis the level of the extracted luciferase from these cells was determined by bioluminescence measurement using the luciferase assay system (Promega, Mannheim, Germany). In addition, a ß-galactosidase plasmid was cotransfected as internal standard.
Assaying yeast growth for [Dat Sar] 3 CsA sensitivity
To investigate cyclophilin-independent relative sensitivity of cells to the growth inhibition by [Dat Sar] 3 CsA, the wild-type strain JK93da (wt) and the isogenic strain KDY98.4a (∆12) lacking the 12 authentic immunophilins were used (20, 31) . Samples of cell suspensions with similar OD 600 of the strains to be tested were used in the presence of CsA or [Dat Sar] 3 CsA under lithium cation stress. The yeast strains were grown to early log phase at 30°C. Serial 100-fold dilutions were spotted onto YPD medium with or without 100 mM LiCl and with or without 10 µM inhibitor (32) . Stock solutions of the inhibitors were prepared in ethanol. All media contained 1% ethanol (31) . Incubation was at 22°C for 5 days.
Results
Biochemical characterization of Sar 3 modified CsA derivatives
CsA derivatives with a modified Sar 3 residue were prepared by established chemical procedures ( Fig. 1 ) (15) . All compounds showed low nanomolar affinity for Cyp18 (Table 1) , the prerequisite for calcineurin inhibition by binary drug/Cyp18 complexes. Surprisingly, several compounds were able to inhibit calcineurin in vitro on their own. The prior binding to Cyp18, the CsA presenter protein for calcineurin inhibition, was not required (Table 1 ; Fig. 2a , upper panel).
Based on the inhibition of Cyp18 and calcineurin, compounds with new types of inhibitory properties were discovered in our study ( properties similar to that of CsA, inhibiting calcineurin only in their complex forms with Cyp18.
As reported previously (1, 33) , the calcineurin phosphatase activity assay using pnitrophenyl phosphate (pNPP) as substrate did not reveal inhibition of dephosphorylation by CsA/Cyp18 but instead showed activation at high concentration of this complex (33 at concentrations up to 100 µ M (Fig. 3b) (Fig. 4b upper panel) . Without anti-CD3/CD28, the proliferation rate was smaller than 1% of the cells.
To investigate the influence of [Dat Sar] 3 CsA on cytokine production of T cells, lymphocytes IL-2 and IFN-γ expression were determined after stimulation of PBMCs with PMA/ionomycin, using immunofluorescence and cytometric analysis of intracellular cytokine expression (36) (Fig. 4a, lower panel) (38) .
[Dat Sar] 3 CsA inhibits calcineurin in a Cyp-independent manner in vivo
To demonstrate that [Dat Sar] 3 CsA can inhibit calcineurin in a Cyp-independent manner in vivo, we tested its effect in the S. cerevisiae strain KDY98.4a (∆12) (20) , in which the 12 immunophilins (all Cyps and FKBPs) were deleted. Calcineurin is involved in the regulation of cation homeostasis in S. cerevisiae (31) . CsA treatment abolished the growth of salt stressed wt-strain through inhibiting calcineurin by the Cyp/CsA binary complex. In contrast, CsA was not able to alternate the growth of the salt stressed ∆12-strain (20) . Interestingly, as shown in figure   7 , [Dat Sar] 3 CsA caused the same degree of growth inhibition in wt-and ∆12-strain under high concentrations of Li + ions.
Discussion
CsA acts bifunctionally in cells, causing both Cyp inhibition and calcineurin inhibition by different parts of the molecule. According to the current models, the CsA residues 9 to 2 are responsible for Cyp18 binding. After forming a complex with Cyp18, the CsA/Cyp18 is able to bind to and inhibit calcineurin through a gain-of-function mechanism involving the residues 4 to 7 of CsA. Among the human Cyps, the most abundant cytosolic Cyp18 was found as major receptor protein for CsA (3). Various CsA derivatives have been applied as useful agents in studying the immunosuppressive mechanism of CsA and signal transduction pathways in activated T cells (8, 10 It has been demonstrated that calcineurin binds to and dephosphorylates NFAT (46) . As a result, NFAT undergoes a conformational change, which enables it to localize nuclearly and bind to DNA (47 CsA derivatives 1 to 6 with modified Sar 3 residue. Sorted T cells were stimulated and measured as described in Figure 4 , in the presence of exogenous IL-2 receptor γ-chain-dependent cytokines IL-2 (10 IU/ml) or IL-7 (10 ng/ml), or IL-15 (10 ng/ml). 
